☆ 4.6 Article

A Highly Sensitive and Specific SARS-CoV-2 Spike- and Nucleoprotein-Based Fluorescent Multiplex Immunoassay (FMIA) to Measure IgG, IgA, and IgM Class Antibodies

MICROBIOLOGY SPECTRUM (2021)

Related references

Note: Only part of the references are listed.

Article Immunology

Persistence of neutralizing antibodies a year after SARS-CoV-2 infection in humans

Anu Haveri et al.

Summary: According to a study, 89% of individuals infected with the WT SARS-CoV-2 strain still had neutralizing antibodies against the WT virus for at least 13 months, and 97% had S-IgG antibodies. On the other hand, only 36% of individuals still had N-IgG antibodies at 13 months. Patients with severe infections had higher antibody levels and are likely to remain seropositive for a longer period of time. Lower neutralizing antibody titers against variants compared to the WT virus, especially after a mild disease, suggest reduced protection against VOCs.

EUROPEAN JOURNAL OF IMMUNOLOGY (2021)

Add to Collection

Article Infectious Diseases

SARS-CoV-2-directed antibodies persist for more than six months in a cohort with mild to moderate COVID-19

Vivian Glueck et al.

Summary: This study followed the serological immune responses of front-line healthcare workers after PCR-confirmed COVID-19 for 30 weeks, finding that the majority retained IgG antibodies after 12 weeks and 90% remained positive at 30 weeks, while IgA and IgM responses declined more rapidly, with a portion of participants no longer having detectable antibodies at 30 weeks.

INFECTION (2021)

Add to Collection

Article Infectious Diseases

Comparison of six commercially available SARS-CoV-2 antibody assays-Choice of assay depends on intended use

Anna Christine Nilsson et al.

Summary: This study evaluated six commercial serological assays for detection of SARS-CoV-2 antibodies, finding that ELISA assays are most suitable for mild cases, while Livzon LFT and Euroimmun ELISA have the highest specificity, making them suitable for seroprevalence studies.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)

Add to Collection

Article Environmental Sciences

Perceived Barriers to COVID-19 Testing

Pearl A. McElfish et al.

Summary: This study documented perceived barriers to COVID-19 testing, including confusion and uncertainty about testing guidelines and locations, lack of accessible testing sites, perception of nasal swab method as painful, and long wait times for testing results. Through qualitative descriptive analysis, participants were able to express their concerns in their own words, providing insights that can assist public health leaders and healthcare providers in understanding and addressing barriers to COVID-19 testing.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)

Add to Collection

Article Microbiology

Persistence of Anti-SARS-CoV-2 Antibodies Depends on the Analytical Kit: A Report for Up to 10 Months after Infection

Julien Favresse et al.

Summary: This study investigated the temporal dynamic changes of immune response after SARS-CoV-2 infection in hospitalized and non-hospitalized symptomatic patients over a 10-month period. Six different analytical kits were used to detect SARS-CoV-2 antibodies, showing a high inter-methodology variability. Total antibody assays had higher positivity rates and reached peak positivity rates sooner compared to IgG assays, with better inter-assay agreement between them. Stratification by disease severity revealed a much-elevated serological response in hospitalized patients. The waning effect of serological response reported in some studies may depend on the assay used.

MICROORGANISMS (2021)

Add to Collection

Article Medicine, General & Internal

Estimating the effectiveness of routine asymptomatic PCR testing at different frequencies for the detection of SARS-CoV-2 infections

Joel Hellewell et al.

Summary: The study used Bayesian statistical model to analyze PCR testing data of UK healthcare workers, finding that the detection probability peaked at 77% 4 days after infection but decreased to 50% by 10 days. Testing every other day was estimated to detect 57% of symptomatic cases before onset and 94% of asymptomatic cases within 7 days if results are returned promptly.

BMC MEDICINE (2021)

Add to Collection

Article Immunology

Persistence of Antibody and Cellular Immune Responses in Coronavirus Disease 2019 Patients Over Nine Months After Infection

Lin Yao et al.

Summary: This study investigated the humoral and T and B cell responses in COVID-19 patients up to 343 days after infection. It found that most patients still had virus-specific immune memory responses approximately 1 year post-infection, which is promising for prevention from reinfection and vaccination strategies.

JOURNAL OF INFECTIOUS DISEASES (2021)

Add to Collection

Letter Medicine, General & Internal

WHO International Standard for anti-SARS-CoV-2 immunoglobulin

Paul A. Kristiansen et al.

LANCET (2021)

Add to Collection

Review Multidisciplinary Sciences

Comparison of seroprevalence of SARS-CoV-2 infections with cumulative and imputed COVID-19 cases: Systematic review

Oyungerel Byambasuren et al.

Summary: The SARS-CoV-2 seroprevalence is below herd immunity in all countries studied, but the estimated number of infections is much higher than the reported cases and deaths in almost all locations. Most seropositive individuals experienced COVID-like symptoms before, indicating a significant under-ascertainment of SARS-CoV-2 infections due to undertesting of symptomatic individuals.

PLOS ONE (2021)

Add to Collection

Article Infectious Diseases

Estimating asymptomatic, undetected and total cases for the COVID-19 outbreak in Wuhan: a mathematical modeling study

Xi Huo et al.

Summary: This study analyzed the complete outbreak data of COVID-19 in Wuhan, assessed the impact of public health interventions, and estimated asymptomatic, undetected, and total cases. Results showed that the transmission rate increased significantly before and after the lockdown, with around 20% of infections being asymptomatic.

BMC INFECTIOUS DISEASES (2021)

Add to Collection

Article Cell Biology

Undiagnosed SARS-CoV-2 seropositivity during the first 6 months of the COVID-19 pandemic in the United States

Heather Kalish et al.

Summary: The study analyzed undiagnosed SARS-CoV-2 infections in the United States and found a high prevalence rate, with different seropositivity estimates among various racial, age, gender, ethnic, and urban/rural groups. Data indicated that as of mid-July 2020, there were an estimated 16.8 million undiagnosed infections in the United States, with 4.8 undiagnosed cases for every diagnosed case of COVID-19.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Add to Collection

Article Multidisciplinary Sciences

COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants

Pinja Jalkanen et al.

Summary: The study shows that the second dose of the BNT162b2 vaccine can induce cross-neutralization to some extent of SARS-CoV-2 variants, providing partial protection. Despite the reduced neutralization effect on the B.1.351 variant, the majority of vaccinees still have some level of protection.

NATURE COMMUNICATIONS (2021)

Add to Collection

Article Multidisciplinary Sciences

Analytic comparison between three high-throughput commercial SARS-CoV-2 antibody assays reveals minor discrepancies in a high-incidence population

Gheyath K. Nasrallah et al.

Summary: The performance of three automated commercial serological IgG-based assays for assessing SARS-CoV-2 infection was investigated in a high exposure setting. All three assays showed comparable performance and excellent agreement, but at least 20% of individuals with past or current infection were missed. Commercial antibody assays may substantially underestimate previous infection, especially when infection rates are high.

SCIENTIFIC REPORTS (2021)

Add to Collection

Article Immunology

A Combination of N and S Antigens With IgA and IgG Measurement Strengthens the Accuracy of SARS-CoV-2 Serodiagnostics

Pinja Jalkanen et al.

Summary: Utilizing SARS-CoV-2 nucleoprotein (N) and receptor binding domain (RBD) as antigens in enzyme immunoassays (EIA) among COVID-19 patients showed sensitivity of 77% in the acute phase and 100% in the convalescent phase. Furthermore, SARS-CoV-2 infection significantly increased humoral immune responses against other human coronaviruses.

JOURNAL OF INFECTIOUS DISEASES (2021)

Add to Collection

Article Immunology

Antibody Responses 8 Months after Asymptomatic or Mild SARS-CoV-2 Infection

Pyoeng Gyun Choe et al.

Summary: A study investigated antibody responses of 58 individuals 8 months after infection with severe acute respiratory syndrome coronavirus 2, showing high seropositivity rates for 3 out of 4 immunoassays used.

EMERGING INFECTIOUS DISEASES (2021)

Add to Collection

Article Virology

Changes in SARS-CoV-2 Spike versus Nucleoprotein Antibody Responses Impact the Estimates of Infections in Population-Based Seroprevalence Studies

Craig Fenwick et al.

Summary: In this study, antibody responses to SARS-CoV-2 were evaluated in acute and postinfection subjects. The results show that responses against viral S and N proteins were equally sensitive in acute phase, but N responses decreased in postinfection phase while S responses persisted. The most sensitive assay used the native S protein trimer, suggesting its importance in estimating SARS-CoV-2 infections and assessing vaccine-induced responses.

JOURNAL OF VIROLOGY (2021)

Add to Collection

Article Infectious Diseases

Serological and molecular findings during SARS-CoV-2 infection: the first case study in Finland, January to February 2020

Anu Haveri et al.

EUROSURVEILLANCE (2020)

Add to Collection

Article Virology

Performance of six SARS-CoV-2 immunoassays in comparison with microneutralisation

A. J. Jaaskelainen et al.

JOURNAL OF CLINICAL VIROLOGY (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections

Quan-Xin Long et al.

NATURE MEDICINE (2020)

Add to Collection

Article Biotechnology & Applied Microbiology

Evaluation of SARS-CoV-2 serology assays reveals a range of test performance

Jeffrey D. Whitman et al.

NATURE BIOTECHNOLOGY (2020)

Add to Collection

Article Immunology

Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients

Anita S. Iyer et al.

SCIENCE IMMUNOLOGY (2020)

Add to Collection

Article Immunology

Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome

Katharina Roltgen et al.

SCIENCE IMMUNOLOGY (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19

Xiangyu Chen et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

Add to Collection

Article Multidisciplinary Sciences

Development and Evaluation of a Multiplexed Immunoassay for Simultaneous Detection of Serum IgG Antibodies to Six Human Coronaviruses

Suvang U. Trivedi et al.

SCIENTIFIC REPORTS (2019)

Add to Collection

Review Chemistry, Medicinal

Antibody pharmacokinetics and pharmacodynamics

ED Lobo et al.

JOURNAL OF PHARMACEUTICAL SCIENCES (2004)

Add to Collection

© Peeref 2019-2024. All rights reserved.